Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19.
<h4>Introduction</h4>Assessment of inpatient mortality risk in COVID-19 patients is important for guiding clinical decision-making. High sensitivity cardiac troponin T (hs-cTnT) is a biomarker of cardiac injury associated with a worse prognosis in COVID-19. We explored how hs-cTnT could...
Main Authors: | Alexander Liu, Robert Hammond, Kenneth Chan, Chukwugozie Chukwuenweniwe, Rebecca Johnson, Duaa Khair, Eleanor Duck, Oluwaseun Olubodun, Kristian Barwick, Winston Banya, James Stirrup, Peter D Donnelly, Juan Carlos Kaski, Anthony R M Coates |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0284523 |
Similar Items
-
Low CRB-65 Scores Effectively Rule out Adverse Clinical Outcomes in COVID-19 Irrespective of Chest Radiographic Abnormalities
by: Alexander Liu, et al.
Published: (2023-08-01) -
Characterisation of Ferritin–Lymphocyte Ratio in COVID-19
by: Alexander Liu, et al.
Published: (2023-10-01) -
Comparison of Lymphocyte–CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19
by: Alexander Liu, et al.
Published: (2023-05-01) -
Copeptin with high-sensitivity troponin at presentation is not inferior to serial troponin measurements for ruling out acute myocardial infarction
by: Kyung Su Kim, et al.
Published: (2020-03-01) -
A Single High-Sensitivity Cardiac Troponin T Strategy for Ruling Out Myocardial Infarction
by: Patrik Gilje, et al.
Published: (2024-01-01)